Virtually any medication can cause sores, rashes, or other skin lesions, and over 90% of drugs taken by mouth or injection have been linked to skin reactions of some kind.1PubMed Central. An inventory of medicinal products causing skin rash: Clinical and regulatory lessons These reactions range from a mild rash that fades on its own to life-threatening blistering that requires intensive care. Understanding which drugs tend to cause which patterns, and which reactions demand urgent attention, matters more than memorizing a list of culprits.
Why So Many Different Drugs Affect the Skin
The skin is the body’s largest organ and one of the first places the immune system announces that something has gone wrong. When a drug triggers an immune response or directly damages cells, the skin often shows it before anything else does. Drug-induced skin reactions can be sorted by how they look: widespread rashes, hives, clusters of tiny pus-filled bumps, blisters, or areas of tissue death.2PubMed. Drugs and the skin: A concise review of cutaneous adverse drug reactions They can also be sorted by timing. Some appear within minutes or hours, while others take days or weeks to surface. The mechanism varies too: some reactions are straightforward dose-related toxicity, while others are immune-mediated and unpredictable, meaning they strike certain people and spare others on the same drug.
Among the drug classes most frequently associated with skin rash are cancer drugs (especially protein kinase inhibitors), monoclonal antibodies, antivirals, and retinoids.1PubMed Central. An inventory of medicinal products causing skin rash: Clinical and regulatory lessons But common everyday medications like antibiotics, anti-seizure drugs, and nonsteroidal anti-inflammatory drugs (NSAIDs) are responsible for a huge share of reactions simply because so many people take them. Roughly 1 to 4% of people on multiple medications develop a skin reaction, and about 10% of hospitalized patients experience one.3PubMed Central. Causes and Management of Cutaneous Adverse Drug Reactions: A Comprehensive Review
The Most Common Pattern: Widespread Rash
The reaction people encounter most often is a morbilliform (measles-like) eruption: flat or slightly raised pink-to-red spots that spread across the torso and limbs, usually appearing one to two weeks after starting a new drug. Antibiotics like amoxicillin and ampicillin are classic triggers, along with anti-seizure medications such as phenytoin and carbamazepine, and the gout drug allopurinol. This type of rash is itchy and unpleasant but generally not dangerous on its own. It typically fades within a week or two of stopping the drug.
The catch is that a widespread rash can sometimes be the opening act for something more serious. If it is accompanied by fever, facial swelling, swollen lymph nodes, or signs of organ involvement, the picture changes dramatically. That combination points toward DRESS syndrome (Drug Reaction with Eosinophilia and Systemic Symptoms), a severe reaction where the immune system goes haywire and can damage the liver, kidneys, or heart in addition to the skin.4PubMed Central. DRESS syndrome: A literature review and treatment algorithm Anticonvulsants, allopurinol, sulfonamide antibiotics, and certain antiretroviral drugs are among the most common DRESS triggers. The tricky part is that DRESS can appear two to eight weeks after starting the medication, long enough that patients and clinicians sometimes fail to connect the rash to the drug.
When Blisters Signal an Emergency
Stevens-Johnson syndrome (SJS) and toxic epidermal necrolysis (TEN) sit at the severe end of the spectrum. In these conditions, the skin literally detaches from underlying tissue. SJS involves less than 10% of the body surface area; TEN involves more than 30%. The mechanism is an aggressive immune attack in which the body’s own cells kill off skin cells in large numbers.5PubMed Central. A Compilation of Drug Etiologies of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis The result is painful blistering, skin sloughing, and mucosal involvement affecting the eyes, mouth, or genitals. Mortality rates for TEN can exceed 30%, and survivors often deal with long-term scarring, vision problems, and other complications.
The drugs most strongly linked to SJS/TEN overlap substantially with those causing DRESS: sulfonamide antibiotics, allopurinol, anticonvulsants (lamotrigine, carbamazepine, phenytoin, phenobarbital), and certain NSAIDs like piroxicam. Early warning signs include a burning or painful rash, especially if it involves the mucous membranes of the mouth and eyes. Anyone who develops blistering, skin peeling, or painful sores in the mouth while on a new medication should seek emergency care immediately. The single most important treatment step is stopping the offending drug as quickly as possible.
Fixed Drug Eruptions: Sores That Come Back in the Same Spot
Not every drug-induced lesion is widespread. Fixed drug eruptions are round, well-defined patches that appear in the exact same location every time the person takes the triggering medication. They often look like dark red or purple circles, and in severe cases the center blisters and erodes into an open sore. Between episodes, the spots may leave behind a brownish discoloration that persists for months. Common locations include the extremities, lips, and genitalia.6PubMed Central. Fixed-drug Eruptions: What can we Learn from a Case Series?
What makes fixed drug eruptions biologically unusual is the way the immune system “remembers” the site. Immune cells that react to the drug take up permanent residence in the affected patch of skin, surviving there for years even without any drug exposure. When the drug is reintroduced, those resident cells reactivate and launch a localized attack on the surrounding skin, which is why the lesion always recurs in the same place.7PubMed. In vivo dynamics of intraepidermal CD8+ T cells and CD4+ T cells during the evolution of fixed drug eruption NSAIDs, trimethoprim-sulfamethoxazole, and tetracycline antibiotics are frequent triggers. Because the reaction is so localized, people sometimes mistake it for a herpes outbreak or an insect bite, and the true drug connection goes unrecognized for years.
Drugs That Make Your Skin React to Sunlight
Some drugs do not damage the skin on their own but set you up for exaggerated damage from ultraviolet light. These photosensitivity reactions come in two varieties. The more common type, phototoxicity, works like a chemical amplifier for sunburn: the drug or its breakdown products absorb UV light and generate reactive molecules that directly harm skin cells. The result is intense redness, swelling, and sometimes blistering on sun-exposed areas, appearing within hours of sun exposure.8PubMed Central. Drug-Induced Photosensitivity: Clinical Types of Phototoxicity and Photoallergy and Pathogenetic Mechanisms
The rarer type, photoallergy, is an immune-mediated reaction. The drug interacts with UV radiation to form a new compound that the immune system recognizes as foreign, triggering an eczema-like rash that typically takes a day or two to develop.9PubMed. Phototoxic and photoallergic cutaneous drug reactions Tetracycline antibiotics (especially doxycycline), fluoroquinolones, thiazide diuretics, amiodarone, and certain NSAIDs are well-known photosensitizers. If you have been prescribed one of these drugs, protective clothing and rigorous sunscreen use are genuinely important rather than optional. The lesions themselves heal once sun exposure stops and the drug is cleared, but repeated phototoxic episodes can cause lasting hyperpigmentation.
Skin Reactions From Chemotherapy and Targeted Cancer Drugs
Cancer treatment occupies its own category because the drugs are designed to kill rapidly dividing cells, and skin cells divide fast. Traditional chemotherapy agents like capecitabine and doxorubicin cause a distinctive reaction called palmar-plantar erythrodysesthesia, informally known as hand-foot syndrome. The palms and soles become red, swollen, and painful, and in more severe cases the skin peels or cracks open. The condition usually peaks a few weeks into treatment and resolves once the drug is stopped or the dose is lowered.10PubMed Central. Palmar-plantar Erythrodysesthesia with Genital Involvement Secondary to Capecitabine Chemoradiotherapy: A Case Report
Targeted cancer drugs, particularly those that block the epidermal growth factor receptor (EGFR), cause a different kind of skin problem. Because EGFR plays a role in normal skin-cell growth, blocking it produces an acne-like rash of small red bumps and pustules concentrated on the face, chest, and back. Dry skin, fissures (painful cracks, especially around fingertips and toenails), and changes to hair and nails are also common.11PubMed Central. Dermatologic Reactions to Targeted Therapy: A Focus on Epidermal Growth Factor Receptor Inhibitors and Nursing Care Ironically, the severity of the rash from EGFR inhibitors has been associated with better cancer outcomes, so oncologists sometimes interpret a strong skin reaction as a sign the drug is working. That does not make the skin symptoms any less miserable, but it does change how aggressively a patient and doctor might manage them versus simply stopping the drug.
Pustular Eruptions and Drug-Induced Blistering Diseases
Acute generalized exanthematous pustulosis (AGEP) is a reaction where dozens to hundreds of tiny, sterile pus-filled bumps erupt across the skin, often on a background of widespread redness. It looks alarming and is frequently mistaken for a skin infection, but cultures come back negative because the pustules contain immune cells, not bacteria. Antibiotics (particularly beta-lactams like amoxicillin and cephalosporins) are the most common triggers, and the reaction typically appears within a few days of starting the drug. The interplay between a recent viral infection and simultaneous drug exposure may increase susceptibility by priming the immune system before the drug pushes it over the edge.12PubMed Central. Acute Generalized Exanthematous Pustulosis Following the Administration of Cephalexin: A Case Report and Review of the Literature AGEP generally resolves within about two weeks of stopping the drug, and the outlook is good, though it can rarely be complicated by secondary infection of the denuded skin.
Some drugs can also provoke autoimmune blistering diseases that closely mimic naturally occurring ones. Drug-induced pemphigus, for example, produces fragile blisters on the skin and mucous membranes. The culprit drugs, most famously penicillamine and captopril, appear to trigger the body to produce antibodies against its own skin-adhesion proteins. The antibodies seen in drug-induced pemphigus are molecularly identical to those found in patients who develop pemphigus without any drug trigger, which means the drug effectively tricks the immune system into a full-blown autoimmune disease.13PubMed. Drug-induced pemphigus: autoantibodies directed against the pemphigus antigen complexes are present in penicillamine and captopril-induced pemphigus In many cases, stopping the drug allows the condition to slowly resolve, but some patients require additional immunosuppressive treatment.
Warfarin-Induced Skin Necrosis and Vascular Damage
Warfarin, the widely prescribed blood thinner, can paradoxically cause skin death in the first week or so of treatment. This happens because warfarin initially depletes certain natural anticlotting proteins (particularly protein C) faster than it depletes the clotting factors it is meant to suppress. The result is a brief window of increased clotting tendency, which can cause small blood vessels in the skin to clot off, starving the tissue of oxygen. The affected areas turn purple, become extremely painful, and develop patches of frank tissue death.14PubMed Central. Warfarin-induced skin necrosis Fatty areas like the breasts, abdomen, buttocks, and thighs are most vulnerable. The risk is highest in people who have an underlying protein C or protein S deficiency, which is why bridging with another anticoagulant during the first days of warfarin therapy is standard practice. If necrosis does develop, the affected skin may require surgical removal and grafting.
Drug-induced vasculitis is a broader pattern in which a medication triggers inflammation of the blood vessel walls, leading to a rash of small reddish-purple spots (purpura) that do not blanch when pressed. The process is believed to involve immune complexes depositing in vessel walls and provoking inflammation.15Springer Link. Drug-Induced vasculitis Hydralazine, certain antibiotics, and TNF inhibitors used for autoimmune conditions are among the known triggers. In most cases, the vasculitis resolves once the drug is withdrawn, though some patients need a course of corticosteroids to tamp down the inflammation.
Illicit Drugs and Skin Necrosis
The question of which drugs cause skin sores extends beyond the pharmacy. Cocaine adulterated with levamisole, a veterinary deworming agent, has been responsible for striking cases of skin necrosis, particularly affecting the ears, nose, and cheeks. Levamisole triggers an immune-mediated attack on neutrophils and blood vessel walls, producing purplish-black areas of tissue death that can be disfiguring.16PubMed Central. Levamisole-adulterated cocaine induced skin necrosis of nose, ears, and extremities: Case report The reaction mimics autoimmune vasculitis so closely that patients often test positive for the same antibodies seen in naturally occurring autoimmune conditions, which can confuse the clinical picture. Levamisole contamination has been widespread in cocaine supplies for years, and clinicians who see unexplained skin necrosis, especially involving the ears or nose, now routinely ask about cocaine use.
Intravenous drug use more broadly causes skin problems through different pathways: direct tissue damage from caustic injected substances, infections from non-sterile technique, and vascular compromise from chronic injection into the same sites. Methamphetamine use is associated with compulsive skin picking (“meth mites”), which creates open sores and secondary infections. These are technically self-inflicted wounds rather than direct drug-induced lesions, but they are so common among methamphetamine users that they are functionally inseparable from the drug’s effects on behavior and perception.
Topical Steroids and Rebound Skin Damage
A somewhat paradoxical source of drug-induced skin lesions is the prolonged use and abrupt discontinuation of topical corticosteroids, the very creams prescribed to treat skin problems. Topical steroid withdrawal (TSW) is characterized by red, burning, painful skin that peels and cracks, often worse than the original condition the steroid was prescribed for.17PubMed Central. Breaking the cycle: a comprehensive exploration of topical steroid addiction and withdrawal It tends to follow prolonged use of mid- to high-potency steroids and is described as a rebound effect: the skin has adapted to the drug’s anti-inflammatory action, and removing it abruptly unmasks a surge of inflammation. The recovery period can last months, and the experience is distressing enough that online patient communities have formed around it. Clinicians sometimes taper steroid use gradually rather than stopping cold to minimize rebound, though the evidence base for optimal withdrawal strategies is still developing.
Methotrexate, used for conditions ranging from rheumatoid arthritis to cancer, can cause skin ulceration as a toxic side effect, even in patients who are not taking it for skin disease.18PubMed. Cutaneous ulceration: an unusual sign of methotrexate toxicity–first report in a patient without psoriasis The ulcers can appear at sites of existing skin damage or on previously normal skin, and they are a signal that the drug has accumulated to toxic levels. Dose adjustment or drug discontinuation is the primary response.
Why Some People React and Others Don’t
One of the most frustrating aspects of drug-induced skin reactions is their unpredictability. Two people can take the same medication at the same dose, and one develops a devastating skin reaction while the other has no trouble at all. Genetics explains a large part of this. Variations in human leukocyte antigen (HLA) genes, which shape how the immune system recognizes foreign molecules, strongly influence who develops severe skin reactions to specific drugs.19PubMed Central. A Comprehensive Review of HLA and Severe Cutaneous Adverse Drug Reactions: Implication for Clinical Pharmacogenomics and Precision Medicine The strength of these genetic associations ranges from moderate to extreme depending on the drug and the population studied, with sensitivity estimates running from roughly 50% to 100%.20PubMed. Pharmacogenetic biomarkers associated with risk of developing severe drug eruptions and clinical implementation of HLA genetic testing
The best-studied example is allopurinol, the gout medication. Carrying a specific HLA variant called HLA-B*58:01 increases the risk of a severe skin reaction to allopurinol by over a hundredfold.21PubMed Central. HLA-B*58:01 genotyping prevalence and the association with allopurinol-induced severe cutaneous adverse reactions: a living systematic review and meta-analysis That variant is more common in people of Southeast Asian, African American, and Korean descent, which means the risk of allopurinol-related skin reactions is not evenly distributed across populations. Similarly, the variant HLA-B*15:02 is strongly linked to carbamazepine-induced SJS/TEN in people of Southeast Asian heritage, and screening for it before prescribing carbamazepine is now recommended by regulatory agencies in several countries. These are genuine advances in prevention: a simple blood test before starting a high-risk drug can identify the patients who should never receive it.
What To Do If You Suspect a Drug Is Causing Skin Problems
The diagnosis of a drug-induced skin reaction is largely clinical, meaning it relies on a careful history and physical examination rather than a single definitive test.22PubMed Central. Adverse cutaneous drug reaction The most important clue is timing: when did the rash start relative to the medication? A reaction appearing one to three weeks after starting a drug, or within hours of restarting one you have taken before, fits the typical drug-reaction timeline. The location and appearance of the lesions narrow the possibilities further. A rash limited to sun-exposed areas points to photosensitivity. Recurring sores always in the same spot suggest a fixed drug eruption. Blistering that involves the mouth or eyes is a red flag for SJS/TEN.
Stopping the suspected drug is the most important intervention for almost every type of drug-induced skin reaction.3PubMed Central. Causes and Management of Cutaneous Adverse Drug Reactions: A Comprehensive Review For mild reactions, symptomatic treatment with antihistamines and topical corticosteroids is usually sufficient. For severe reactions like SJS/TEN or DRESS, hospitalization is often necessary, sometimes in a burn unit for extensive skin detachment. The key is not to wait and see whether a rash “gets better on its own” when any of the warning signs of severe reactions are present: blistering, skin peeling, mucosal involvement, fever, or signs of organ dysfunction. Calling your prescriber at the first sign of a new rash is reasonable, even if the rash turns out to be harmless. Most drug-induced skin reactions are mild, but the severe ones progress fast, and early drug withdrawal is the single factor most consistently linked to better outcomes.
Drugs That Cause Skin Ulcers Through Tissue Extravasation
A category that gets less public attention is skin damage from intravenous drugs that leak out of the vein into surrounding tissue during infusion, known as extravasation. Certain chemotherapy agents like doxorubicin and vincristine are classified as vesicants because even small amounts leaking into tissue can cause severe local destruction, progressing from redness and swelling to deep ulceration and necrosis over days. Healthcare staff are trained to monitor IV sites closely during infusions of these drugs, and established protocols exist for immediate intervention if a leak is suspected, but extravasation injuries still occur. The resulting wounds can be slow to heal and sometimes require surgical intervention. Calcium and potassium solutions given intravenously can cause similar, though usually less severe, tissue injury if they infiltrate.
Beyond extravasation, some oral medications are directly toxic to skin that has been compromised by other means. Hydroxyurea, used for sickle cell disease and certain blood cancers, is well known for causing leg ulcers that are slow to heal, typically around the ankles. The ulcers are thought to result from the drug’s effects on blood vessel function and wound healing rather than from an immune reaction. They look like ordinary venous ulcers and can persist as long as the drug is continued, which puts clinicians in a difficult position when the drug is controlling a serious underlying disease. Recognizing that the ulcers are drug-related rather than coincidental is the first step toward managing them, because the treatment involves either stopping hydroxyurea or accepting the ulcers as a trade-off.